GMT Share Price Performance
zł0
-6.52 (-100.00%)
Price zł0
Share Pricen/a
Genomtec S.A. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
GMT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Genomtec S.A. Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 30, 2026
- -0.61
- -26,983.33%
- -30,710.00%
- 6.3%
About GMT
- Founded
- 2016
- Employees
- 32
- CEO
- WebsiteView website
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company’s flagship project is the Genomtec ID, a diagnostic platform that enables the detection of pathogens, such as viruses, bacteria, and fungi, as well as genetic mutations through the analysis of biological material of patients using swabs, urine, and saliva. It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas. Genomtec S.A. was founded in 2016 and is based in Wroclaw, Poland.
